HOME | In Silico Onc Med

ONCOSIMULATOR_DIAGRAM_AND_DEBCAST_G_STAM

SHRIKING_TUMOUR_WITH_BLACK_LINEWS_NEW.jp

In Silico Oncology and

In Silico Medicine

Augmented with

Artificial

Intelligence

(ISO&ISM-aug-with-AI)

Institute of Communication and Computer Systems

School of Electrical and Computer Engineering

National Technical University of Athens

Director and Founder

Research Professor Georgios Stamatakos

Father of in silico medicine

E-Mail: gestam@central.ntua.gr

(Green colored text is clickable)

Invited lecture on in silico oncology given to the European Parliament by Research Professor Georgios Stamatakos on 21 February 2024.

On 21 February 2024, a European Parliament (EP) info event on in silico medicine and in silico oncology took place in the Altiero Spinelli building in Brussels with global live broadcast. G.Stamatakos gave the lecture titled «The Role of Computer Modelling and Simulation in Medicine. The Paradigm of In Silico Oncology». In silico oncology, including digital twins in oncology, addresses the European Commission’s prioritized research area entitled “EU Mission Cancer”. Strongly supportive and even enthusiastic feedback was provided by individuals and entities residing in the European Union, the USA and China. Relevant information and audio and visual material are available at: https://www.vph-institute.org/news/event-at-the-european-parliament-on-in-silico-medicine-and-in-silico-oncology.html .

The Yuan community and technology platform: Research professor and father of in silico medicine Georgios Stamatakos reviews how in silico medicine has progressed since its inception in 2002, and indicative milestones achieved over these past two decades (2023).

History of Science: the birth of the digital twin in oncology and the development of the Oncosimulator(2022).

An article of the international Virtual Physiological Human Institute (VPHi), based in Greater Brussels, Belgium, EU, on the first digital twin ("Clinical Oncosimulator") in oncology and beyond. The digital twin had been developed under the leadership of G. Stamatakos and was presented at Massachusetts General Hospital and Harvard Medical School, Greater Boston, USA in 2007.

Prof Georgios Stamatakos gets interviewed by the Yuan on the globally acknowledged emergence of in silico medicine 2022).

An article of the international Virtual Physiological Human Institute (VPHi), based in Greater Brussels, Belgium, EU, on the global emergence of in silico medicine in Greece under the leadership of G. Stamatakos.

Research Prof. G. Stamatakos is interviewed by the Chinese and international AI technology community platform THE YUAN on the globally acknowledged emergence of in silico (computational) medicine in ECE, NTUA, Greece (2022).

An article of the School of Electrical and Computer Engineering (ECE), National Technical University of Athens (NTUA) on the emergence of in silico medicine in ECE, NTUA, Greece under the leadership of G. Stamatakos.

G. S. Stamatakos, initiator of in silico medicine, is interviewed by the global Yuan AI tech community platform and magazine, Shanghai, China, on the birth of in silico medicine in Greece and its universal evolution. The article title is In-silico medicine: a new paradigm in modern healthcare emerges in Greece (2022).

If you wish to stay updated on the research achievements and the educational activities of the group, you can also visit our LinkedIn, Facebook and Twitter pages. Frequent updates, news and extensive visual material are included therein.

A brief introductory presentation of the In Silico Oncology and In Silico Medicine Group in pdf format (2021) is available here (clickable pdf icon):

In Silico Oncology and In Silico Medicine Group (ISO&ISM_G)